Investor Alert

New York Markets Open in:

Market Snapshot Analyst Ratings

Humana Inc.

NYS: HUM

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
Humana Inc.

After Hours

 --Quotes are delayed by 20 min

Jun 7, 2023, 7:51 p.m.

HUM
/zigman2/quotes/203095337/composite

$

505.40

Change

+0.71 +0.14%

Volume

Volume 47,650

Quotes are delayed by 20 min

/zigman2/quotes/203095337/composite

Previous close

$ 511.12

$ 504.69

Change

-6.43 -1.26%

Day low

Day high

$502.03

$511.40

Open

52 week low

52 week high

$418.70

$571.30

Open

Company Description

Humana Inc. engages in the provision of health insurance services. It operates through the Insurance and CenterWell segments. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as contract with CMS to administer the Limited I...

Humana Inc. engages in the provision of health insurance services. It operates through the Insurance and CenterWell segments. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as contract with CMS to administer the Limited Income Newly Eligible Transition, or LI-NET, prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits, which refer to as state-based contracts. The CenterWell segment represents payor-agnostic healthcare services offerings, including pharmacy dispensing services, provider services, and home services. The company was founded by David A. Jones, Sr., and Wendell Cherry on August 18, 1961 and is headquartered in Louisville, KY.

Valuation

P/E Current

23.73

P/E Ratio (with extraordinary items)

21.12

P/E Ratio (without extraordinary items)

23.20

Price to Sales Ratio

0.70

Price to Book Ratio

4.18

Price to Cash Flow Ratio

14.19

Enterprise Value to EBITDA

14.26

Enterprise Value to Sales

0.75

Total Debt to Enterprise Value

0.15

Efficiency

Revenue/Employee

1,384,829.00

Income Per Employee

41,818.00

Total Asset Turnover

2.10

Liquidity

Current Ratio

1.52

Profitability

Operating Margin

4.54

Pretax Margin

3.84

Net Margin

3.02

Return on Assets

6.34

Return on Equity

17.88

Return on Total Capital

14.75

Return on Invested Capital

10.80

Capital Structure

Total Debt to Total Equity

76.76

Total Debt to Total Capital

43.43

Total Debt to Total Assets

26.88

Long-Term Debt to Equity

61.98

Long-Term Debt to Total Capital

35.07

Officers and Executives

Name Age Officer Since Title
Mr. Bruce Dale Broussard 58 2011 President
Ms. Susan M. Diamond 47 2006 Segment President-Home Business
Dr. Alefiyah Mesiwala - 2021 Chief Medical Officer
Mr. Sam Deshpande - 2017 SVP, Chief Risk & Technology Officer
Mr. Timothy S. Huval 55 2012 Chief Human Resources & Administrative Officer

Insider Actions

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
05/05/2023 Susan M. Diamond
Chief Financial Officer 		700   0
05/04/2023 Susan M. Diamond
Chief Financial Officer 		100   Gift at $0 per share. 0
05/04/2023 Susan M. Diamond
Chief Financial Officer 		1,500   Disposition at $526.75 per share. 790,125
05/04/2023 Susan M. Diamond
Chief Financial Officer 		2,656   Disposition at $526.02 per share. 1,397,109
05/04/2023 Susan M. Diamond
Chief Financial Officer 		713   Derivative/Non-derivative trans. at $350.79 per share. 250,113
05/04/2023 Susan M. Diamond
Chief Financial Officer 		1,148   Derivative/Non-derivative trans. at $350.79 per share. 402,706
05/04/2023 Susan M. Diamond
Chief Financial Officer 		1,508   Derivative/Non-derivative trans. at $376.61 per share. 567,927
03/01/2023 David T. Feinberg
Director 		441   Derivative/Non-derivative trans. at $0 per share. 0
02/28/2023 David A. Jones
Director 		10,000   Gift at $0 per share. 0
02/27/2023 Bruce Dale Broussard
President & CEO; Director 		17,575   Disposition at $505.85 per share. 8,890,313
02/27/2023 Timothy S. Huval
Chief Administrative Officer 		2,628   Disposition at $510.3 per share. 1,341,068
02/27/2023 Joseph C Ventura
Chief Legal Officer 		2,048   Disposition at $507.97 per share. 1,040,322
02/27/2023 Joseph C Ventura
Chief Legal Officer 		69   Gift at $0 per share. 0
02/24/2023 Bruce Dale Broussard
President & CEO; Director 		10,919   Derivative/Non-derivative trans. at $510.24 per share. 5,571,310
02/24/2023 Susan M. Diamond
Chief Financial Officer 		1,125   Derivative/Non-derivative trans. at $510.24 per share. 574,020
02/24/2023 Sam Deshpande
Chief Information Officer 		1,541   Derivative/Non-derivative trans. at $510.24 per share. 786,279
02/24/2023 Vishal Agrawal
Chief Strat & Corp Dev Officer 		1,427   Derivative/Non-derivative trans. at $510.24 per share. 728,112
02/24/2023 William Kevin Fleming
Seg Pres, Pharmacy Sol & CCAO 		1,802   Derivative/Non-derivative trans. at $510.24 per share. 919,452
02/24/2023 Timothy S. Huval
Chief Administrative Officer 		1,678   Derivative/Non-derivative trans. at $510.24 per share. 856,182
02/24/2023 Joseph C Ventura
Chief Legal Officer 		1,245   Derivative/Non-derivative trans. at $510.24 per share. 635,248
02/24/2023 Sue Schick
Seg Pres. Grp. & Military Bus. 		399   Derivative/Non-derivative trans. at $510.24 per share. 203,585
02/24/2023 George Renaudin
President, Medicare & Medicaid 		347   Derivative/Non-derivative trans. at $510.24 per share. 177,053
02/24/2023 Bruce Dale Broussard
President & CEO; Director 		28,494   Derivative/Non-derivative trans. at $0 per share. 0
02/24/2023 Susan M. Diamond
Chief Financial Officer 		3,039   Derivative/Non-derivative trans. at $0 per share. 0
02/24/2023 Sam Deshpande
Chief Information Officer 		4,053   Derivative/Non-derivative trans. at $0 per share. 0
02/24/2023 Vishal Agrawal
Chief Strat & Corp Dev Officer 		3,799   Derivative/Non-derivative trans. at $0 per share. 0
02/24/2023 William Kevin Fleming
Seg Pres, Pharmacy Sol & CCAO 		4,560   Derivative/Non-derivative trans. at $0 per share. 0
02/24/2023 Timothy S. Huval
Chief Administrative Officer 		4,306   Derivative/Non-derivative trans. at $0 per share. 0
02/24/2023 Joseph C Ventura
Chief Legal Officer 		3,293   Derivative/Non-derivative trans. at $0 per share. 0
02/24/2023 Sue Schick
Seg Pres. Grp. & Military Bus. 		1,267   Derivative/Non-derivative trans. at $0 per share. 0
02/24/2023 George Renaudin
President, Medicare & Medicaid 		1,393   Derivative/Non-derivative trans. at $0 per share. 0
01/03/2023 David A. Jones
Director 		380   Award at $0 per share. 0
01/03/2023 James J. O'Brien
Director 		380   Award at $0 per share. 0
01/03/2023 Jorge S. Mesquita
Director 		380   Award at $0 per share. 0
12/21/2022 David A. Jones
Director 		15,000   Disposition at $501.72 per share. 7,525,800
12/16/2022 Timothy S. Huval
Chief Administrative Officer 		635   Disposition at $497.71 per share. 316,045
12/15/2022 Bruce Dale Broussard
President & CEO; Director 		860   Derivative/Non-derivative trans. at $510.02 per share. 438,617
12/15/2022 Bruce Dale Broussard
President & CEO; Director 		970   Derivative/Non-derivative trans. at $510.02 per share. 494,719
12/15/2022 Bruce Dale Broussard
President & CEO; Director 		1,052   Derivative/Non-derivative trans. at $510.02 per share. 536,541
12/15/2022 Susan M. Diamond
Chief Financial Officer 		238   Derivative/Non-derivative trans. at $510.02 per share. 121,384
12/15/2022 Susan M. Diamond
Chief Financial Officer 		171   Derivative/Non-derivative trans. at $510.02 per share. 87,213
12/15/2022 Susan M. Diamond
Chief Financial Officer 		133   Derivative/Non-derivative trans. at $510.02 per share. 67,832
12/15/2022 Sam Deshpande
Chief Information Officer 		160   Derivative/Non-derivative trans. at $510.02 per share. 81,603
12/15/2022 Sam Deshpande
Chief Information Officer 		158   Derivative/Non-derivative trans. at $510.02 per share. 80,583
12/15/2022 Sam Deshpande
Chief Information Officer 		172   Derivative/Non-derivative trans. at $510.02 per share. 87,723
12/15/2022 Vishal Agrawal
Chief Strat & Corp Dev Officer 		139   Derivative/Non-derivative trans. at $510.02 per share. 70,892
12/15/2022 Vishal Agrawal
Chief Strat & Corp Dev Officer 		149   Derivative/Non-derivative trans. at $510.02 per share. 75,992
12/15/2022 Vishal Agrawal
Chief Strat & Corp Dev Officer 		162   Derivative/Non-derivative trans. at $510.02 per share. 82,623
12/15/2022 William Kevin Fleming
Seg Pres, Pharmacy Sol & CCAO 		159   Derivative/Non-derivative trans. at $510.02 per share. 81,093
12/15/2022 William Kevin Fleming
Seg Pres, Pharmacy Sol & CCAO 		179   Derivative/Non-derivative trans. at $510.02 per share. 91,293
12/15/2022 William Kevin Fleming
Seg Pres, Pharmacy Sol & CCAO 		197   Derivative/Non-derivative trans. at $510.02 per share. 100,473
12/15/2022 Timothy Alan Wheatley
Segment President, Retail 		230   Derivative/Non-derivative trans. at $510.02 per share. 117,304
12/15/2022 Timothy Alan Wheatley
Segment President, Retail 		257   Derivative/Non-derivative trans. at $510.02 per share. 131,075
12/15/2022 Timothy Alan Wheatley
Segment President, Retail 		266   Derivative/Non-derivative trans. at $510.02 per share. 135,665
12/15/2022 Timothy S. Huval
Chief Administrative Officer 		165   Derivative/Non-derivative trans. at $510.02 per share. 84,153
12/15/2022 Timothy S. Huval
Chief Administrative Officer 		185   Derivative/Non-derivative trans. at $510.02 per share. 94,353
12/15/2022 Timothy S. Huval
Chief Administrative Officer 		185   Derivative/Non-derivative trans. at $510.02 per share. 94,353
12/15/2022 Joseph C Ventura
Chief Legal Officer 		169   Derivative/Non-derivative trans. at $510.02 per share. 86,193
12/15/2022 Joseph C Ventura
Chief Legal Officer 		174   Derivative/Non-derivative trans. at $510.02 per share. 88,743
12/15/2022 Joseph C Ventura
Chief Legal Officer 		144   Derivative/Non-derivative trans. at $510.02 per share. 73,442
12/15/2022 Sue Schick
Seg Pres. Grp. & Military Bus. 		114   Derivative/Non-derivative trans. at $510.02 per share. 58,142
12/15/2022 Sue Schick
Seg Pres. Grp. & Military Bus. 		87   Derivative/Non-derivative trans. at $510.02 per share. 44,371
12/15/2022 Sue Schick
Seg Pres. Grp. & Military Bus. 		633   Derivative/Non-derivative trans. at $510.02 per share. 322,842
12/15/2022 Sue Schick
Seg Pres. Grp. & Military Bus. 		74   Derivative/Non-derivative trans. at $510.02 per share. 37,741
12/15/2022 Andrew C. Agwunobi
Seg. President, Home Solutions 		79   Derivative/Non-derivative trans. at $510.02 per share. 40,291
12/15/2022 Bruce Dale Broussard
President & CEO; Director 		2,183   Derivative/Non-derivative trans. at $0 per share. 0
12/15/2022 Bruce Dale Broussard
President & CEO; Director 		2,464   Derivative/Non-derivative trans. at $0 per share. 0
12/15/2022 Bruce Dale Broussard
President & CEO; Director 		2,673   Derivative/Non-derivative trans. at $0 per share. 0
12/15/2022 Susan M. Diamond
Chief Financial Officer 		511   Derivative/Non-derivative trans. at $0 per share. 0
12/15/2022 Susan M. Diamond
Chief Financial Officer 		366   Derivative/Non-derivative trans. at $0 per share. 0
12/15/2022 Susan M. Diamond
Chief Financial Officer 		285   Derivative/Non-derivative trans. at $0 per share. 0
12/15/2022 Sam Deshpande
Chief Information Officer 		353   Derivative/Non-derivative trans. at $0 per share. 0
12/15/2022 Sam Deshpande
Chief Information Officer 		350   Derivative/Non-derivative trans. at $0 per share. 0
12/15/2022 Sam Deshpande
Chief Information Officer 		380   Derivative/Non-derivative trans. at $0 per share. 0
12/15/2022 Vishal Agrawal
Chief Strat & Corp Dev Officer 		308   Derivative/Non-derivative trans. at $0 per share. 0
12/15/2022 Vishal Agrawal
Chief Strat & Corp Dev Officer 		329   Derivative/Non-derivative trans. at $0 per share. 0
12/15/2022 Vishal Agrawal
Chief Strat & Corp Dev Officer 		357   Derivative/Non-derivative trans. at $0 per share. 0
12/15/2022 William Kevin Fleming
Seg Pres, Pharmacy Sol & CCAO 		345   Derivative/Non-derivative trans. at $0 per share. 0
12/15/2022 William Kevin Fleming
Seg Pres, Pharmacy Sol & CCAO 		389   Derivative/Non-derivative trans. at $0 per share. 0
12/15/2022 William Kevin Fleming
Seg Pres, Pharmacy Sol & CCAO 		428   Derivative/Non-derivative trans. at $0 per share. 0
12/15/2022 Timothy Alan Wheatley
Segment President, Retail 		494   Derivative/Non-derivative trans. at $0 per share. 0
12/15/2022 Timothy Alan Wheatley
Segment President, Retail 		550   Derivative/Non-derivative trans. at $0 per share. 0
12/15/2022 Timothy Alan Wheatley
Segment President, Retail 		570   Derivative/Non-derivative trans. at $0 per share. 0
12/15/2022 Timothy S. Huval
Chief Administrative Officer 		361   Derivative/Non-derivative trans. at $0 per share. 0
12/15/2022 Timothy S. Huval
Chief Administrative Officer 		405   Derivative/Non-derivative trans. at $0 per share. 0
12/15/2022 Timothy S. Huval
Chief Administrative Officer 		404   Derivative/Non-derivative trans. at $0 per share. 0
12/15/2022 Joseph C Ventura
Chief Legal Officer 		361   Derivative/Non-derivative trans. at $0 per share. 0
12/15/2022 Joseph C Ventura
Chief Legal Officer 		372   Derivative/Non-derivative trans. at $0 per share. 0
12/15/2022 Joseph C Ventura
Chief Legal Officer 		309   Derivative/Non-derivative trans. at $0 per share. 0
12/15/2022 Sue Schick
Seg Pres. Grp. & Military Bus. 		247   Derivative/Non-derivative trans. at $0 per share. 0
12/15/2022 Sue Schick
Seg Pres. Grp. & Military Bus. 		189   Derivative/Non-derivative trans. at $0 per share. 0
12/15/2022 Sue Schick
Seg Pres. Grp. & Military Bus. 		1,603   Derivative/Non-derivative trans. at $0 per share. 0
12/15/2022 Sue Schick
Seg Pres. Grp. & Military Bus. 		238   Derivative/Non-derivative trans. at $0 per share. 0
12/15/2022 Andrew C. Agwunobi
Seg. President, Home Solutions 		261   Derivative/Non-derivative trans. at $0 per share. 0
/news/latest/company/us/hum

MarketWatch News on HUM

  1. Humana Inc. stock falls Wednesday, underperforms market

    4:45 p.m. June 7, 2023

    - MarketWatch Automation

  2. Humana Inc. stock falls Tuesday, underperforms market

    4:45 p.m. June 6, 2023

    - MarketWatch Automation

  3. Humana Inc. stock outperforms competitors on strong trading day

    4:46 p.m. June 5, 2023

    - MarketWatch Automation

  4. Humana Inc. stock rises Friday, still underperforms market

    4:46 p.m. June 2, 2023

    - MarketWatch Automation

  5. Humana Inc. stock outperforms competitors on strong trading day

    5:01 p.m. June 1, 2023

    - MarketWatch Automation

  6. Humana Inc. stock outperforms market on strong trading day

    5:00 p.m. May 31, 2023

    - MarketWatch Automation

  7. Humana Inc. stock falls Tuesday, underperforms market

    5:00 p.m. May 30, 2023

    - MarketWatch Automation

  8. Humana Inc. stock underperforms Friday when compared to competitors

    5:00 p.m. May 26, 2023

    - MarketWatch Automation

  9. Humana Inc. stock falls Thursday, underperforms market

    5:01 p.m. May 25, 2023

    - MarketWatch Automation

  10. Humana Inc. stock falls Wednesday, still outperforms market

    5:00 p.m. May 24, 2023

    - MarketWatch Automation

  11. Humana Inc. stock falls Tuesday, underperforms market

    5:00 p.m. May 23, 2023

    - MarketWatch Automation

  13. Humana Inc. stock outperforms market on strong trading day

    5:00 p.m. May 22, 2023

    - MarketWatch Automation

  14. Humana Inc. stock outperforms market despite losses on the day

    5:00 p.m. May 19, 2023

    - MarketWatch Automation

  15. Humana Inc. stock falls Thursday, underperforms market

    5:00 p.m. May 18, 2023

    - MarketWatch Automation

  16. Humana Inc. stock rises Wednesday, still underperforms market

    5:00 p.m. May 17, 2023

    - MarketWatch Automation

  17. Humana Inc. stock outperforms competitors despite losses on the day

    5:01 p.m. May 16, 2023

    - MarketWatch Automation

  18. Humana Inc. stock underperforms Monday when compared to competitors

    5:01 p.m. May 15, 2023

    - MarketWatch Automation

  19. Humana Inc. stock falls Friday, underperforms market

    5:01 p.m. May 12, 2023

    - MarketWatch Automation

  20. Humana Inc. stock outperforms competitors despite losses on the day

    5:01 p.m. May 11, 2023

    - MarketWatch Automation

  21. Loading more headlines...
/news/nonmarketwatch/company/us/hum

Other News on HUM

  1. 10-Q: HUMANA INC

    3:09 p.m. April 26, 2023

    - Edgar Online - (EDG = 10Q, 10K)

  2. Investors Warm Back Up to Health Insurance Stocks After Selloff

    2:32 a.m. April 12, 2023

    - The Wall Street Journal Interactive Edition

  3. Dow Industrials Rise as Oil Prices Jump

    4:38 a.m. April 4, 2023

    - The Wall Street Journal Interactive Edition

  4. Investors Are Too Spooked by Washington’s PBM Crackdown

    3:27 p.m. May 25, 2023

    - The Wall Street Journal Interactive Edition

  5. Drug Middlemen Accused of Price Fixing by Ohio Attorney General

    9:41 p.m. June 1, 2023

    - The Wall Street Journal Interactive Edition

  6. Why Some Investors Are Still Waiting for Discounts on Corporate Bonds

    12:38 p.m. June 6, 2023

    - The Wall Street Journal Interactive Edition

  7. Health Insurers Square Off With Biden Administration Over Medicare Payments

    3:34 a.m. March 3, 2023

    - The Wall Street Journal Interactive Edition

  8. Humana Exits Employer Insurance Business

    3:33 a.m. Feb. 24, 2023

    - The Wall Street Journal Interactive Edition

  9. 10-K: HUMANA INC

    4:14 p.m. Feb. 16, 2023

    - Edgar Online - (EDG = 10Q, 10K)

  10. CVS Reaches $10.6 Billion Deal to Buy Oak Street Health

    3:32 a.m. Feb. 9, 2023

    - The Wall Street Journal Interactive Edition

  11. CVS Nearing $10.5 Billion Deal for Primary-Care Provider Oak Street Health

    12:07 p.m. Feb. 7, 2023

    - The Wall Street Journal Interactive Edition

  12. Private Medicare Plans Face Tough Audits That Could Cost Billions

    8:18 a.m. Feb. 7, 2023

    - The Wall Street Journal Interactive Edition

  13. The Government Thinks It Is Overpaying for Medicare, Spelling Trouble for Insurers

    3:32 a.m. Jan. 24, 2023

    - The Wall Street Journal Interactive Edition

  14. Rite Aid CEO Heyward Donigan Leaves

    3:32 a.m. Jan. 10, 2023

    - The Wall Street Journal Interactive Edition

  15. Nonprofit Health Plans Set to Combine

    3:43 p.m. Dec. 14, 2022

    - The Wall Street Journal Interactive Edition

  16. With Debt Coming Due, Investment-Grade Companies Are Paying Up, Too

    3:32 a.m. Dec. 2, 2022

    - The Wall Street Journal Interactive Edition

  17. That Knee Surgery You Postponed Could Soon Hobble Insurance Giants

    3:33 a.m. Nov. 30, 2022

    - The Wall Street Journal Interactive Edition

At a Glance

Humana, Inc.

500 West Main Street

Louisville, Kentucky 40202

Phone

1 5025801000

Industry

Life Insurance

Sector

Financial Services

Fiscal Year-end

12/2023

View SEC Filings

Revenue

$92.92B

Net Income

$2.81B

2022 Sales Growth

11.1%

Employees

67,100

Annual Report for HUM

/news/pressrelease/company/us/hum

Press Releases on HUM

  7. Humana Board Declares Payment of Quarterly Dividend to Stockholders

    6:30 a.m. April 20, 2023

    - BusinessWire - BZX

  9. Humana Announces Additional $40 Million Investment in Affordable Housing

    1:00 p.m. April 13, 2023

    - BusinessWire - BZX

  13. Humana Healthy Horizons Commits $488,000 to Improve Health of Texans

    9:00 a.m. March 30, 2023

    - BusinessWire - BZX

  14. Humana Inc. to Release First Quarter 2023 Results on April 26, 2023

    4:15 p.m. March 29, 2023

    - BusinessWire - BZX

Link to MarketWatch's Slice.